U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046728) titled 'Efficay and Safety of DAROMUN on Patient Treated by Intralesionnal Injection: DAROMEL' on June 23.
Brief Summary: Melanoma is a malignant tumor originating from melanocytes, with a high metastatic potential, particularly in advanced stages. The standard treatment for resectable melanomas has traditionally been surgery, often followed by adjuvant therapy to reduce the risk of recurrence. However, the emergence of neoadjuvant/perioperative therapies, administered prior to surgery, has revolutionized the management of patients with stage IIIB-C-D melanoma presenting with locoregional macroscopic metastases. Another therapeutic approach ...